Journals / Kulak Burun Boğaz İhtisas Dergisi / 2012 / Cilt: 22 - Sayı: 4

Homosistein, B12 vitamini ve folik asit düzeylerinin vertigo ile ilişkisi

The relationship of homocysteine, vitamin B12, folic acid levels with vertigo

Pages
214–218
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

We found that there is no relationship of homocysteine, vitamin B12, folic acid levels with PVD.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Objectives: In this study the relationship of serum homocysteine, vitamin B12, folic acid levels and peripheral vestibular dysfunction (PVD) was investigated.
📊
Key Findings & Data:Patients and Methods: Forty-one patients (31 females, 10 males; mean age 57.3±14.3 years; range 12 to 80 years) who admitted to Baskent University Hospital Ear Nose and Throat Department between the dates of April 2005 - December 2007 with complaint of vertigo were prospectively analyzed and diagnosed using audio-vestibular test, at the same time serum homocysteine, vitamin B12, folic acid measurements was done from the blood samples of patients.
💡
Conclusion & Impact:We found that there is no relationship of homocysteine, vitamin B12, folic acid levels with PVD.
🔬Design:Research Article
📍Scope:2005 Verileri
⚙️Variables:Domain Parameters

Abstract

Objectives: In this study the relationship of serum homocysteine, vitamin B12, folic acid levels and peripheral vestibular dysfunction (PVD) was investigated. Patients and Methods: Forty-one patients (31 females, 10 males; mean age 57.3±14.3 years; range 12 to 80 years) who admitted to Baskent University Hospital Ear Nose and Throat Department between the dates of April 2005 - December 2007 with complaint of vertigo were prospectively analyzed and diagnosed using audio-vestibular test, at the same time serum homocysteine, vitamin B12, folic acid measurements was done from the blood samples of patients. The patients were divided into three groups as Meniere’s disease, vestibular neurinitis, and benign paroxismal positional vertigo (BPPV) according to the diagnoses and serum homocysteine, vitamin B12, folic acid levels of patients were compared to normal values in and between groups. Results: Of the patients, 29.3% (n=12) were diagnosed with Meniere’s disease, 36.6% (n=15) with vestibular neurinitis, and 34.1% (n=14) with BPPV. Serum homocysteine leves of patients were 12.42±3.56 umol/L, 11.32±4.14 umol/L and 10.72±2.95 umol/L (p>0.05) in Meniere’s disease, vestibular neurinitis, and BPPV respectively; vitamin B12 levels were 371.58±141.35 pg/ml, 288.13±139.51 pg/ml, 352.14±150.41 pg/ml (p>0.05) respectively and folic acid levels were 8.76±3.2 umol/L, 10.63±6.59 umol/L, 8.8±3.18 umol/L (p>0.05) respectively. The values were similar in all patients. No statistically significant difference was found in and between groups comparing with normal values. Conclusion: This is the first prospective study investigating the relationship of serum homocystein, vitamin B12 and folic acid levels with PVD. We found that there is no relationship of homocysteine, vitamin B12, folic acid levels with PVD.

Özet

Amaç: Bu çalışmada serum homosistein, vitamin B12, folik asit düzeyleri ile periferal vestibüler disfonksiyon (PVD) arasındaki ilişki incelendi. Hastalar ve Yöntemler: Baş dönmesi yakınması ile Nisan 2005 - Aralık 2007 tarihleri arasında Başkent Üniversitesi Hastanesi Kulak Burun Boğaz Anabilim Dalı’na başvuran 41 hasta (31 kadın, 10 erkek; ort. yaş 57.3±14.3 yıl; dağılım 12-80 yıl) odyovestibüler testler ile prospektif olarak incelendi ve tanıları konuldu, aynı zamanda hastalardan alınan kan örneğinden serum homosistein, vitamin B12 ve folik asit düzeylerinin ölçümü yapıldı. Hastalar konulan tanı doğrultusunda Meniere hastalığı, vestibüler nörinit ve benign paroksismal pozisyonel vertigo (BPPV) üç gruba ayrıldı. Hastaların serum homosistein, vitamin B12, folik asit düzeyleri gruplar arasında ve grup içinde normal değerlere oranlanarak karşılaştırıldı. Bulgular: Hastaların %29.3’üne (n=12) Meniere hastalığı, %36.6’sına (n=15) vestibüler nörinitis ve %34.1’ine (n=14) BPPV tanısı konuldu. Serum homosistein düzeyleri sırasıyla Meniere hastalığı, vestibüler nörinit ve BPPV grubunda 12.42±3.56 umol/L, 11.32±4.14 umol/L ve 10.72±2.95 umol/L (p>0.05); vitamin B12 düzeyleri sırasıyla 371.58±141.35 pg/ml, 288.13±139.51 pg/ml, 352.14±150.41 pg/ml (p>0.05) ve folik asit düzeyleri sırasıyla 8.76±3.2 umol/L, 10.63±6.59 umol/L, 8.8±3.18 umol/L (p>0.05) olarak hastaların tümünde benzer bulundu. İstatistiksel olarak normal değerlere oranla grup içinde ve gruplar arasında anlamlı bir farklılık bulunmadı. Sonuç: Bu çalışma serum homosistein, vitamin B12, folik asit düzeyleri ile PVD arasındaki ilişkiyi inceleyen ilk prospektif çalışmadır. Homosistein, vitamin B12 ve folik asit düzeyleri ile PVD arasında bir ilişki bulunmadı.

🔖

Cite This Article

AYDIN, E., BABAKURBAN, S. T., ÖZGİRGİN, O. N., ÖZLÜOĞLU, L. N. (2012). Homosistein, B12 vitamini ve folik asit düzeylerinin vertigo ile ilişkisi. Kulak Burun Boğaz İhtisas Dergisi, Cilt: 22 - Sayı: 4, 214–218. https://ajindex.com/articles/342575

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (15)

  1. Rybak LR Metabolic disorders of the vestibular system. Otolaryngol Head Neck Surg 1995;112:128-32
  2. Gomez CR, Cruz-Flores S, Malkoff MD, Sauer CM, Burch CM. Isolated vertigo as a manifestation of vertebrobasilar ischemia. Neurology 1996;47:94-7
  3. Fattori B, Nacci A, Casani A, Cristofani R, Sagripanti A. Hemostatic alterations in patients with acute, unilateral vestibular paresis. Otolaryngol Head Neck Surg 2001;124:401-7
  4. Cumurcu T, Şahin S, Aydin E. Serum homocysteine, vitamin B 12 and folic acid levels in different types of glaucoma. BMC Ophthalmol 2006;6:6
  5. Fattori B, Nacci A, Ghilardi PL, Bruschini L, Matteucci F, Ursino F. Acute peripheral vertigo: involvement of the hemostatic system. Int Tinnitus J 2003;9:124-9
  6. Shimoji T, Yamada M. Vertigo and dizziness related to platelet aggregability. No To Shinkei 1998;50:548-54. [Abstract] 7. Asaküra M, Kato I, Takahashi K, Okada T, Minami S, Takeyama I, et al. Increased platelet aggregability in patients with vertigo, sudden deafness and facial palsy. Acta Otolaryngol Suppl 1995;520:399-400
  7. Grotemeyer KH. Abnormal hemorheological parameters in vertebrobasilar-insufficiency. Acta Neurol Scand 1990;81:529-32
  8. Noda Y, Nakamura M, Sasaki M, Kosugi T. Inhibitors of coagulation-fibrinolysis system and platelet function in patients with vertigo. Auris Nasus Larynx 1986;13 Suppl 1:S75-9
  9. RacekJ, Rusnâkovâ H, Trefil L, Siala KK. The influence of folate and antioxidants on homocysteine levels and oxidative stress in patients with hyperlipidemia and hyperhomocysteinemia. Physiol Res 2005;54:87-95
  10. Gok U, Halifeoglu I, Canatan H, Yildiz M, Gursu MF, Gur B. Comparative analysis of serum homocysteine, folic acid and Vitamin B12 levels in patients with noise-induced hearing loss. Auris Nasus Larynx 2004;31:19-22
  11. Scaramella JG. Hyperhomocysteinemia and left internal jugular vein thrombosis with Meniere's symptom complex. Ear Nose Throat J 2003;82:856, 859-60, 865
  12. Lentz SR. Mechanisms of thrombosis in hyperhomocysteinemia. Curr Opin Hematol 1998;5:343-9
  13. Weiss N. Mechanisms of increased vascular oxidant stress in hyperhomocys-teinemia and its impact on endothelial function. Curr Drug Metab 2005;6:27-36
  14. Kado DM, Karlamangla AS, Huang MH, Troen A, Rowe JW, Selhub J, et al. Homocysteine versus the vitamins folate, B6, and B12 as predictors of cognitive function and decline in older high-functioning adults: MacArthur Studies of Successful Aging. Am J Med 2005;118:161-7
  15. Homocy